Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Paolo Casale is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive, nephron-sparing surgery for kidney cancer and improving outcomes in prostate cancer management. His major contributions lie in refining robotic-assisted partial nephrectomy (RAPN) techniques and developing predictive tools for surgical success and cancer recurrence. As a key contributor to the Transatlantic Robotic Nephron-sparing Surgery Study Group, Dr. Casale has helped establish benchmarks for RAPN outcomes, with his landmark 2018 study on techniques and outcomes accumulating 55 citations. He has pioneered the use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer (26 citations) and validated the prostate health index as an independent predictor of early biochemical recurrence after radical prostatectomy (26 citations). His work also includes a prospective randomized trial demonstrating the safety of early catheter removal after robotic prostatectomy (25 citations) and a critical review of factors influencing renal function preservation after nephron-sparing surgery (13 citations). Dr. Casale’s research has directly shaped clinical protocols, enabling more personalized surgical planning and better long-term renal function outcomes for patients.